Can we predict dangerous side effects of cancer immunotherapy?
NCT ID NCT07357636
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 940 adult cancer patients starting immunotherapy to understand why some develop immune-related side effects, especially those affecting the brain and nerves. Researchers will collect blood samples and health data over time to find early warning signs. The goal is to better predict and manage these side effects, making immunotherapy safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways to predict and manage immune-related side effects from cancer immunotherapy, improving patient safety and quality of life.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly benefit participants. It may not find clear biomarkers, and results may take years to impact clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Cancer Hospital of Shantou University Medical College
RECRUITINGShantou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 430074, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hainan Hospital of Chinese PLA General Hospital
RECRUITINGSanya, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
the First Affiliated Hospital of Shantou University Medical College
RECRUITINGShantou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact